Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 23 January 2012, 09:00 HKT/SGT
Share:
    

Source: Pharma Regulatory Affairs
National Agency of Drug and Food Control, Indonesia Newly Confirmed Present at 2nd Annual Pharma Regulatory Affairs Asia

SINGAPORE, Jan 23, 2012 - (ACN Newswire) - "Asia regulations keep on changing, in particular in all the established countries like China and Japan. Another change is that many countries don't have regulations at the moment but they are going to have new regulations (e.g. drug-medical device combined product) coming, so they will uniquely register in their country very soon. In the past, you didn't need it. An example of this is India, Hong Kong, Singapore, Malaysia, etc. So there will be two major dynamics that I think companies need to be aware of," said Jack Wong, Regulatory Affairs Director, Johnson and Johnson Medical.

Indeed, like what Jack has mentioned, ensuring regulatory compliance has become one of the biggest challenges for products development in Asia.

Jack Wong will be speaking at the 2nd Annual Pharma Regulatory Affairs Asia conference, which will take place on 25-26 April 2012 in Singapore.

In China, what's the impact of the healthcare system reform on pharma companies?

In Korea, what's the impact of recently IND Regulation changes and what's the next step of regulation updates?

In Vietnam, what is the regulation framework for drug registration and product commercialisation?

In Indonesia, what are the new regulations related to pre-market evaluation?

The 2nd Annual Pharma Regulatory Affairs Asia conference will feature speakers from Thailand FDA, National Agency of Drug and Food Control, Indonesia, DIA, APEC Harmonization Centre, Novartis, AstraZeneca, Johnson & Johnson among the others, and will discuss pharma regulation updates and regulatory compliance in China, India, Korea, Thailand, Vietnam, Indonesia and Philippines.

Drop an email to enquiry@iqpc.com.sg to register for the conference or visit www.pharmaregulatoryaffairsasia.com for the full list of speakers and topics that will be covered at the 2nd Annual Pharma Regulatory Affairs Asia.


Contact:
Bryan Camoens
IQPC Worldwide
Tel: +65-67229406
Email: bryan.camoens@iqpc.com.sg


Topic: Press release summary
Source: Pharma Regulatory Affairs

Sectors: Trade Shows, BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
WINS Acquires Control of 5 Newbuilt DP Crew Transfer Vessels Through Acquisition of Controlling Stake in Fast Offshore Supply Pte Ltd  
June 27, 2026 21:58 HKT/SGT
Mitsubishi Shipbuilding Receives Order for the MAmmoSS(R) Ammonia Fuel Handling System  
Saturday, June 27, 2026 12:16:00 PM
MHI Study Results Indicate Potential Cost Reductions in the Decarbonization Value Chain Using Green Hydrogen and Ammonia Produced in India  
Saturday, June 27, 2026 12:00:00 PM
Foxconn and Sharp Signs Memorandum of Understanding for Strategic Collaboration in New Business Areas  
Saturday, June 27, 2026 11:44:00 AM
DENSO Group Formulates New Environmental Policy "Eco Vision 2035"  
Saturday, June 27, 2026 10:58:00 AM
Everest Medicines Announces NMPA Acceptance of the BLA for LEROCHOL(R), Offering a Potential New Treatment Option for Hypercholesterolemia in China  
June 26, 2026 22:26 HKT/SGT
PT Merdeka Gold Resources Tbk Debuts on the Main Board of HKEX with a Secondary Listing  
June 26, 2026 22:20 HKT/SGT
Tong Ren Tang Healthcare (02667.HK) Targets Hong Kong IPO  
June 26, 2026 21:16 HKT/SGT
IP Go-Global Business Matching Session held in Guangzhou  
June 26, 2026 19:36 HKT/SGT
JCB and PNB Launch New Platinum Credit Card, Empowering Consumers with Greater Value and Lifestyle Benefits  
Friday, June 26, 2026 5:00:00 PM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: